Mark Bach
Patrimonio netto: 56 644 $ in data 31/05/2026
Patrimonio netto: 56 644 $ in data 31/05/2026
Il dott. Mark A. Bach, MD, è vicepresidente senior dello sviluppo clinico presso Ascendis Pharma A/S. Il Dr. Bach è stato precedentemente impiegato come amministratore delegato di Accumulus Synergy, Inc, Head-Asia Pacific Medical Sciences di Janssen Pharmaceuticals, Inc, Vice President-Research & Development di Janssen Pharmaceutical KK, e VP-Clinical Research Operations Worldwide di Merck & Co. Si è laureato al Carleton College, ha conseguito un dottorato all'Università di Chicago e un dottorato al Baylor College of Medicine.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 15/03/2024 | 4.320 ( 0% ) | 56 644 $ | 31/05/2026 |
| Società | Posizione | Fine |
|---|---|---|
| STRUCTURE THERAPEUTICS INC. | Direttore Tecnico/Scientifico/R&S | 18/09/2024 |
Accumulus Synergy, Inc
Accumulus Synergy, Inc Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit industry association | Amministratore Delegato | 01/10/2020 |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Corporate Officer/Principal | 01/08/2019 |
Janssen Pharmaceutical KK
Janssen Pharmaceutical KK Pharmaceuticals: MajorHealth Technology Develops, manufactures, and markets prescription pharmaceutical products | Direttore Tecnico/Scientifico/R&S | 01/11/2012 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/01/2010 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 9 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Health Technology |
Janssen Pharmaceutical KK
Janssen Pharmaceutical KK Pharmaceuticals: MajorHealth Technology Develops, manufactures, and markets prescription pharmaceutical products | Health Technology |
Carleton College
Carleton College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ascendis Pharma A/S
Ascendis Pharma A/S Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapies for metabolic, cardiovascular and ophthalmology | Health Technology |
Structure Therapeutics, Inc.
Structure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops molecule therapeutics to treat chronic diseases | Health Technology |
Accumulus Synergy, Inc
Accumulus Synergy, Inc Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit industry association | Commercial Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale